424
J. H. van Tonder et al.
PAPER
Procedure for Chalcone (4e) in Reactor 2 in the Presence of
sel set to maintain the pressure inside the reactor at the required
constant level by feeding hydrogen from the ballast vessel into the
reactor. Hydrogen gas consumption was recorded electronically as
a function of time and the reaction products were identified by GC-
MS upon completion of the reaction.
Triphenylphosphine
A soln of (Ph3P)3RhCl (1; 20 mg, 0.022 mmol) and Ph3P (3 mg, 0.01
mmol) in CH2Cl2 (5 mL) was injected into a soln of trans-chalcone
(4e; 0.50 g, 2.4 mmol) in CH2Cl2 (25 mL) and the reaction was
executed and followed as described previously.
Procedure for Chalcone (4e) in Reactor 1
A soln of trans-chalcone (4e; 1.10 g, 5.3 mmol) in CH2Cl2 (1 mL)
was injected into a soln of (Ph3P)3RhCl (1; 9 mg, 0.01 mmol) in
CH2Cl2 (9 mL) at 80 °C and 10 bar, and the mixture stirred at that
temperature. As in the case of the liquid substrates, the progress of
the reaction was monitored by hydrogen consumption, whereas the
product was identified by GC-MS.
Acknowledgment
Financial support from Sasol Ltd is gratefully acknowledged.
References
(1) Shimizu, H.; Nagasaki, I.; Saito, T. Tetrahedron 2005, 61,
5405.
(2) Jourdant, A.; González-Zamora, E.; Zhu, J. J. Org. Chem.
2002, 67, 3163.
(3) Dahlenberg, L. Coord. Chem. Rev. 2005, 249, 2962.
(4) As the nonvolatile substrates were solids, they had to be
dissolved in solvent, which necessitated the use of the larger
reactor for better mass transfer.
Ketones 3 and 5e; General Procedure for Solid Substrates 2a–c
and 4e in Reactor 2
A soln of (Ph3P)3RhCl (1; 20 mg, 0.022 mmol) in CH2Cl2 (5 mL)
was injected into the substrate soln in CH2Cl2 (25 mL) at the tem-
perature and pressure indicated in Tables 1 and 2, and the mixture
stirred at that temperature. Samples of the reaction mixture were ob-
tained at regular intervals and analyzed by 1H NMR spectroscopy.
(5) Mahittikul, A.; Prasassarakich, P.; Rempel, G. L. J. Mol.
Catal. A: Chem. 2009, 297, 135.
Chroman-4-one (3a)
1H NMR (300 MHz, CDCl3): d = 7.88 (dd, J = 1.82, 7.87 Hz, 1 H,
H-5), 7.45 (ddd, J = 1.82, 7.27, 8.28 Hz, 1 H, H-7), 6.99 (ddd,
J = 0.81, 7.27, 7.87 Hz, 1 H, H-6), 6.95 (dd, J = 0.81, 8.28 Hz, 1 H,
H-8), 4.52 (t, J = 6.46 Hz, 2 H, H-2), 2.79 (t, J = 6.46 Hz, 2 H, H-
3).9
(6) Yi, C. S.; Lee, D. W. Organometallics 1999, 18, 5152.
(7) (a) Van Laren, M. W.; Duin, M. A.; Klerk, C.; Naglia, M.;
Rogolino, D.; Pelagatti, P.; Bacchi, A.; Pelizzi, C.; Elsevier,
C. J. Organometallics 2002, 21, 1546. (b) Nelson, D. J.; Li,
R.; Brammer, C. J. Org. Chem. 2005, 70, 761.
(8) Kokkinos, N. C.; Lazaridou, A.; Nikolaou, N.;
Papadogianakis, G.; Psaroudakis, N.; Chatzigakis, A. K.;
Papadopoulos, C. E. Appl. Catal., A 2009, 363 (1-2), 129.
(9) He, J.; Zheng, J.; Lui, J.; She, X.; Pan, X. Org. Lett. 2006, 8,
4637.
13C NMR (150.9 MHz, CDCl3): d = 37.88, 67.10, 117.97, 121.45,
127.22, 136.04, 161.96, 191.85.
Dihydrochalcone (5e)
1H NMR (600 MHz, CDCl3): d = 7.97–7.96 (m, 2 H, H-2¢ and H-
6¢), 7.57–7.55 (m, 1 H, ArH), 7.47–7.44 (m, 2 H, ArH), 7.32–7.29
(m, 2 H, ArH), 7.27–7.26 (m, 2 H, ArH), 7.22–7.20 (m, 1 H, ArH),
3.31 (t, J = 7.74 Hz, 2 H, H-b), 3.08 (t, J = 7.74 Hz, 2 H, H-a).10
(10) Hashimoto, N.; Aoyama, T.; Shioiri, T. Chem. Pharm. Bull.
1982, 30, 119.
Synthesis 2010, No. 3, 421–424 © Thieme Stuttgart · New York